| Summary of Stock Options Outstanding under Plans |
The table below provides stock option information for the nine months ended September 30, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Shares |
|
Weighted-
Average
Exercise
Price Per
Share |
|
Weighted-
Average
Remaining
Contractual
Life |
|
Aggregate
Intrinsic
Value of
In-the-
Money
Options |
|
|
|
|
|
|
|
|
(in thousands) |
|
Options outstanding at beginning of period |
364,088 |
|
|
$ |
17.86 |
|
|
5.9 years |
|
$ |
4,548 |
|
(1) |
Options exercised |
(25,750 |
) |
|
$ |
22.06 |
|
|
5.9 years |
|
— |
|
|
Options outstanding at end of period |
338,338 |
|
|
$ |
17.52 |
|
|
5.1 years |
|
$ |
2,498 |
|
(2) |
|
|
|
|
|
|
|
|
|
Options exercisable at end of period |
338,338 |
|
|
$ |
17.52 |
|
|
5.1 years |
|
$ |
2,498 |
|
(2) |
|
|
(1) |
Intrinsic value represents the excess of the closing stock price on the last trading day of the period, which was $30.35 as of December 31, 2017, over the exercise price, multiplied by the number of options.
|
|
|
(2) |
Intrinsic value represents the excess of the closing stock price on the last trading day of the period, which was $24.90 as of September 30, 2018, over the exercise price, multiplied by the number of options.
|
The table below provides stock option information for the three months ended September 30, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Shares |
|
Weighted-
Average
Exercise
Price Per
Share |
|
Weighted-
Average
Remaining
Contractual
Life |
|
Aggregate
Intrinsic
Value of
In-the-
Money
Options |
|
|
|
|
|
|
|
|
(in thousands) |
|
Options outstanding at beginning of period |
338,338 |
|
|
$ |
17.52 |
|
|
5.5 years |
|
$ |
3,657 |
|
(1) |
|
|
|
|
|
|
|
|
|
Options outstanding at end of period |
338,338 |
|
|
$ |
17.52 |
|
|
5.1 years |
|
$ |
2,498 |
|
(2) |
|
|
|
|
|
|
|
|
|
Options exercisable at end of period |
338,338 |
|
|
$ |
17.52 |
|
|
5.1 years |
|
$ |
2,498 |
|
(2) |
|
|
(1) |
Intrinsic value represents the excess of the closing stock price on the last trading day of the period, which was $28.35 as of June 30, 2018, over the exercise price, multiplied by the number of options.
|
|
|
(2) |
Intrinsic value represents the excess of the closing stock price on the last trading day of the period, which was $24.90 as of September 30, 2018, over the exercise price, multiplied by the number of options.
|
|
| Schedule of Restricted Stock Awards |
The table below provides information for restricted stock awards for the three and nine months ended September 30, 2018:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
September 30, 2018 |
|
Nine Months Ended
September 30, 2018 |
|
Number of
Shares |
|
Weighted-
Average
Grant Date
Fair Value
Per Share |
|
Number of
Shares
|
|
Weighted-
Average
Grant Date
Fair Value
Per Share
|
Restricted stock at beginning of period |
315,505 |
|
|
$ |
22.44 |
|
|
317,783 |
|
|
$ |
21.09 |
|
Restricted stock granted |
16,177 |
|
|
25.59 |
|
|
135,571 |
|
|
26.46 |
|
Restricted stock vested |
(3,826 |
) |
|
23.52 |
|
|
(82,480 |
) |
|
26.40 |
|
Restricted stock forfeited |
(12,438 |
) |
|
25.69 |
|
|
(55,456 |
) |
|
15.19 |
|
Restricted stock at end of period |
315,418 |
|
|
23.05 |
|
|
315,418 |
|
|
23.05 |
|
|